Aarti Drugs Ltd.

₹522.25

Aarti Drugs Ltd.

Add Alert
Add Watchlist

₹522.25

₹522.25

-16.8 (-3.12%) - 30 Jul 2025 04:28 PM

About Company

Aarti Drugs Limited was established in the year 1984 and forms part of Aarti Group of Industries with robust R&D Division at Tarapur, Maharashtra Industrial Development Corporation (MIDC) in close vicinity to manufacturing locations. The company is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals and also produces Formulations with its wholly-owned subsidiary - Pinnacle Life Science Private Limited. Products under APIs includes Ciprofloxacin Hydrochloride, Metronidazole, Metformin HCL, Ketoconazole, Ofloxacin etc. whereas Specialty Chemicals includes Benzene Sulphonyl Chloride, Methyl Nicotinate etc.

Market Cap. ₹ 4,767 Cr.
52 Week - High/Low ₹ 635/312
P/E Ratio 26.62
P/B Ratio 4.06
Enterprise Value ₹ 5,079 Cr.
ROE % 12.39
RSI Value 57.85
EMA 50 480.86
EMA 200 449.76
Market Cap. ₹ 4,767 Cr.
52 Week - High/Low ₹ 635/312
P/E Ratio 25.23
P/B Ratio 3.72
Enterprise Value ₹ 5,112 Cr.
ROE % 13.87
RSI Value 57.85
EMA 50 480.86
EMA 200 449.76

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.